Comprometidos con Ayudarle a Acceder a los Medicamentos de Genentech

Saber qué esperar puede suponer una gran diferencia. Podemos ayudarle en todos los pasos necesarios para obtener un medicamento de Genentech.

Preguntas Frecuentes

Acerca de Genentech BioOncology® Access Solutions

Genentech BioOncology Access Solutions es un recurso para personas que toman un medicamento de Genentech. Le brindamos acceso al medicamento que necesita.

Me Preocupa Tener Que Pagar TECENTRIQ

Puede haber opciones para ayudarle a conseguir el medicamento de Genentech que le ha prescrito el médico. Genentech BioOncology Access Solutions puede derivarle a diversas opciones de asistencia a pacientes.

Cómo Conseguir Mi Medicamento

Podría suceder que no le den el medicamento de Genentech inmediatamente. En primer lugar, la consulta de su médico o la farmacia especializada deberán verificar que su plan de seguro médico cubra esta medicamento. Esto es lo que se llama “investigación de prestaciones” (benefits investigation). Quizá deban también enviar Más Información antes de que su plan cubra el medicamento. Esto es lo que se llama “autorización previa” (prior authorization).

Cómo Inscribirse en Genentech BioOncology Access Solutions

  1. Debe rellenar el formulario llamado PAN.
  2. Su médico debe rellenar el formulario llamado SMN. Usted no tiene que rellenar nada en este formulario.
  3. Su médico envía los dos formularios a Genentech BioOncology Access Solutions.

Hay dos formas de rellenar el formulario PAN:

  • Puede rellenar el formulario en línea por internet 
  • Puede descargarlo e imprimirlo para cumplimentarlo en papel

El formulario PAN nos permite comentar su información sobre salud con su médico y su plan de seguro médico. No podemos trabajar con usted sin tener el PAN firmado.

Usted no necesita hacer nada más, pero su médico sí. Debe enviar el formulario llamado Declaración de Necesidad Médica (SMN por sus siglas en inglés). Este formulario nos indica que su médico quiere tratarle con TECENTRIQ. Asegúrese de que el médico nos envía el SMN para que le podamos ayudar.

Usted no tiene que rellenar nada en el formulario SMN.

Mi Plan Médico ha Rechazado la Cobertura de TECENTRIQ

Si su plan de seguro médico no cubre el medicamento de Genentech, usted y la consulta de su médico pueden realizar una apelación. Consulte a su médico para saber si necesita presentar una petición.

Disponemos de recursos para ayudarle a usted y a su médico a realizar una apelación.

Disponemos de recursos para ayudarle a usted y a su médico a realizar una apelación. Usted o la consulta de su médico debe realizar una apelación directamente con su plan de seguro médico.

Esto depende de su plan de seguro médico. Debe preguntar directamente a su plan cuál es su proceso. En ocasiones el proceso de apelación es rápido. No obstante, una apelación puede tardar varios meses si apela varias veces.

Mi Seguro Médico Puede Cambiar

Si su seguro cambia mientras está tomando un medicamento de Genentech, llámenos. Podemos ayudarle a comprender su nueva cobertura.

La GATCF ayuda a las personas que no tienen seguro médico. También ayuda a las personas que, aun contando con un seguro médico, tienen dificultades para pagar sus medicamentos de Genentech. Si reúne los requisitos de la GATCF, podría recibir el medicamento de forma gratuita.

Es responsabilidad suya y de su médico cumplimentar y enviar toda la documentación necesaria a su plan de seguro médico. Genentech no puede garantizar que su plan cubra los tratamientos.

PAN=siglas en inglés de Autorización del Paciente y Aviso de Solicitud Para Transmitir Información Médica a Genentech Access Solutions y a Genentech® Access to Care Foundation.

SMN=siglas en inglés de Declaración de Necesidad Médica.

Important Safety Information & Indication

What it Treats


TECENTRIQ is a prescription medicine used to treat:

A type of bladder and urinary tract cancer called urothelial carcinoma.

  • TECENTRIQ may be used when your bladder cancer:
    • has spread or cannot be removed by surgery, and if you have any one of the following conditions:
    • you are not able to take chemotherapy that contains a medicine called cisplatin, and your doctor has tested your cancer and found high levels of a specific protein on your cancer called programmed death‑ligand 1 (PD‑L1), or
    • you are not able to take chemotherapy that contains any platinum regardless of the levels of PD-L1 on your cancer, or
    • you have tried chemotherapy that contains platinum, and it did not work or is no longer working

The approval of TECENTRIQ in these patients is based on a study that measured response rate and duration of response. There is an ongoing study to confirm clinical benefit.

A type of lung cancer called non-small cell lung cancer (NSCLC).

  • TECENTRIQ may be used when your lung cancer:
    • has spread or grown, and
    • you have tried chemotherapy that contains platinum, and it did not work or is no longer working

If your tumor has an abnormal EGFR or ALK gene, you should have also tried an FDA-approved therapy for tumors with these abnormal genes, and it did not work or is no longer working.

It is not known if TECENTRIQ is safe and effective in children.

Important Safety Information

What is the most important information about TECENTRIQ?

TECENTRIQ can cause your immune system to attack normal organs and tissues and can affect the way they work. These problems can sometimes become serious or life threatening and can lead to death.

Call or see your healthcare provider right away if you get any symptoms of the following problems or these symptoms get worse.

TECENTRIQ can cause serious side effects, including:

  • Lung problems (pneumonitis)–signs and symptoms may include new or worsening cough, shortness of breath, and chest pain
  • Liver problems (hepatitis)–signs and symptoms of hepatitis may include yellowing of your skin or the whites of your eyes, severe nausea or vomiting, pain on the right side of your stomach area (abdomen), drowsiness, dark urine (tea colored), bleeding or bruising more easily than normal, and feeling less hungry than usual
  • Intestinal problems (colitis)–signs and symptoms of colitis may include diarrhea (loose stools) or more bowel movements than usual, blood or mucous in your stools or dark, tarry, sticky stools, and severe stomach area (abdomen) pain or tenderness
  • Hormone gland problems (especially the thyroid, adrenal glands, pancreas, and pituitary)–signs and symptoms that your hormone glands are not working properly may include headaches that will not go away or unusual headaches, extreme tiredness, weight gain or weight loss, dizziness or fainting, feeling more hungry or thirsty than usual, hair loss, changes in mood or behavior (such as decreased sex drive, irritability, or forgetfulness), feeling cold, constipation, your voice gets deeper, urinating more often than usual, nausea or vomiting, and stomach area (abdomen) pain
  • Problems in other organs–signs and symptoms may include severe muscle weakness, numbness or tingling in hands or feet, confusion, blurry vision, double vision, or other vision problems, changes in mood or behavior, extreme sensitivity to light, neck stiffness, eye pain or redness, skin blisters or peeling, chest pain, irregular heartbeat, shortness of breath, or swelling of the ankles
  • Severe infections–signs and symptoms of infection may include fever, cough, flu-like symptoms, pain when urinating, and frequent urination or back pain
  • Severe infusion reactions–signs and symptoms of infusion reactions may include chills or shaking, itching or rash, flushing, shortness of breath or wheezing, swelling of your face or lips, dizziness, fever, feeling like passing out, and back or neck pain

Getting medical treatment right away may help keep these problems from becoming more serious. Your healthcare provider may treat you with corticosteroid or hormone replacement medicines. Your healthcare provider may delay or completely stop treatment with TECENTRIQ if you have severe side effects.

Before you receive TECENTRIQ, tell your healthcare provider about all of your medical conditions, including if you:

  • have immune system problems (such as Crohn’s disease, ulcerative colitis, or lupus); have had an organ transplant; have lung or breathing problems; have liver problems; have a condition that affects your nervous system (such as myasthenia gravis or Guillain-Barre syndrome); or are being treated for an infection
  • are pregnant or plan to become pregnant. TECENTRIQ can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with TECENTRIQ. If you are able to become pregnant:
    • Your healthcare provider should do a pregnancy test before you start treatment with TECENTRIQ.
    • You should use an effective method of birth control during your treatment and for at least 5 months after the last dose of TECENTRIQ.
  • are breastfeeding or plan to breastfeed. It is not known if TECENTRIQ passes into your breast milk. Do not breastfeed during treatment and for at least 5 months after the last dose of TECENTRIQ

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

The most common side effects of TECENTRIQ in people with urothelial carcinoma include:

  • feeling tired
  • decreased appetite
  • nausea
  • constipation
  • urinary tract infection
  • diarrhea
  • fever

The most common side effects of TECENTRIQ in people with non-small cell lung cancer include:

  • feeling tired
  • decreased appetite
  • muscle pain
  • cough
  • shortness of breath

TECENTRIQ may cause fertility problems in females, which may affect the ability to have children. Talk to your healthcare provider if you have concerns about fertility.

These are not all the possible side effects of TECENTRIQ. Ask your healthcare provider or pharmacist for more information. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-FDA-1088 or

You may also report side effects to Genentech at 1-888-835-2555.

Please see [accompanying] full Prescribing Information for additional Important Safety Information.